J&J to file USFDA request to start trials for surgical robots
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.
HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature..
HQ team November 3, 2023: Researchers at Michigan Medicine, University of Michigan, have discovered a key metabolite’s role in regulating DNA repair processes,.
HQ team November 3, 2023: Researchers at Northwestern University have developed a synthetic melanin, a versatile pigment found in nature. This synthetic version.
HQ Team November 1, 2023: A collaboration between the University of Bonn, Utrecht University, and Northeastern University in Boston, alongside NovoBiotic Pharmaceuticals, has.
HQ team October 31, 2023: The US Food and Drug Administration (FDA) has given the green light to Santhera Pharmaceuticals’ drug, Agamree (vamorolone),.
HQ Team October 30, 2023: Researchers at the Indian Institute of Science Education and Research Bhopal (IISER) have developed a transparent biomedical adhesive.
HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.
HQ Team October 30, 2023: Researchers have unraveled a critical mechanism involving the dynein protein, shedding light on how it aids the spread.